Subclinical macroangiopathic target organ damage in type 1 diabetes mellitus patients

References

• Swerdlow AJ, Jones ME. Mortality during 25 years of follow-up of a cohort with diabetes. Int J Epidemiol. 1996;25(6):1250–1261.
   PubMed Web of Science ®Google Scholar
• Soedamah-Muthu SS, Fuller JH, Mulnier HE, et al. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia. 2006;49(4):660–666.
   PubMed Web of Science ®Google Scholar
• Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003;46(6):760–765.
   PubMed Web of Science ®Google Scholar
• Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet. Med. 1999;16(6):466–471.
   PubMed Web of Science ®Google Scholar
• Huxley RR, Peters SA, Mishra GD, et al. Risk af all-cause mortality and vascular events in women versus men with type 1 diabetes: a systemic review and meta-analysis. Lancet Diabetes endocrinol. 2015;3(3):198–206.
   PubMed Web of Science ®Google Scholar
• Soedamah-Muthu SS, Fuller JH, Mulnier HE, et al. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care. 2006;29(4):798–804.
   PubMed Web of Science ®Google Scholar
• Soedamah-Muthu SS, EURODIAB Prospective Complications Study Group, Chaturvedi N, Toeller M, et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care. 2004;27(2):530–537.
   PubMed Web of Science ®Google Scholar
• Conway B, Costacou T, Orchard T. Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes? Diab Vasc Dis Res. 2009; 6(4):223–230.
   PubMed Web of Science ®Google Scholar
• Wadén J, on behalf of the Finnish Diabetic Nephropathy Study Group, Forsblom C, Thorn LM, et al. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes. 2009;58(11):2649–2655.
   PubMed Web of Science ®Google Scholar
• Greenland P, American Heart Association, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2010;56(25):e50–103.
   PubMed Web of Science ®Google Scholar
• Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51(4):527–539.
   PubMed Web of Science ®Google Scholar
• Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness:a systematic review and meta-analysis. J Am CollCardiol. 2010;55(13):1318–1327.
   Web of Science ®Google Scholar
• Goff DC, Jr, Lloyd-Jones DM, Bennet G, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2014;63(25 Pt B):2935–2959.
   PubMed Web of Science ®Google Scholar
• Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2013;34(39):3035–3087.
   PubMed Web of Science ®Google Scholar
• Piepoli MF, ESC Scientific Document Group, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 2016;37(29):2315–2381.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–467.
   PubMed Web of Science ®Google Scholar
• Giannattasio C, Failla M, Piperno A, et al. Early impairment of large artery structure and function in type 1 diabetes mellitus. Diabetologia. 1999;42(8):987–994.
   PubMed Web of Science ®Google Scholar
• Atabek ME, Kurtoglu S, Pirgon O, et al. Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes. Diabetes Res ClinPract. 2006;74(1):33–40.
   PubMed Web of Science ®Google Scholar
• Krantz JS, Mack WJ, Hodis HN, et al. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J. Pediatr. 2004;145(4):452–457.
   PubMed Web of Science ®Google Scholar
• Järvisalo MJ, Raitakari M, Toikka JO, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004;109(14):1750–1755.
   PubMed Web of Science ®Google Scholar
• El-Samahy MH, Tantawy AAG, Adly AAM, et al. Expression of CD4+ CD28null T lymphocytes in children and adolescents with type 1 diabetes mellitus: Relation to microvascular complications, aortic elastic properties, and carotid intima media thickness. Pediatr Diabetes. 2017;18(8):785–793.
   PubMed Web of Science ®Google Scholar
• Frost D, Beischer W. Determinants of carotid artery wall thickening in young patients with type 1 diabetes mellitus. Diabet. Med. 1998;15(10):851–857.
   PubMed Web of Science ®Google Scholar
• Giannattasio C, Failla M, Grappiolo A, et al. Progression of large artery structural and functional alterations in type 1 diabetes. Diabetologia. 2001;44(2):203–208.
   PubMed Web of Science ®Google Scholar
• Vastagh I, Horvath T, Nagy G, et al. Evolution and predictors of morphological and functional arterial changes in the course of type 1 diabetes mellitus. Diabetes Metab. Res. Rev. 2010;26(8):646–655.
   PubMed Web of Science ®Google Scholar
• Frost D, Beischer W. Progression of the carotid artery intima-media thickness in young patients with type 1 diabetes. Diabetes Care. 2003;26(2):545–545.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Price JF, Robertson C, et al. Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration. Diabetes Care. 2015;38(10):1921–1929.
   PubMed Web of Science ®Google Scholar
• Petrie JR, Chaturvedi N, Ford I, et al. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017;5(8):597–609.
   PubMed Web of Science ®Google Scholar
• Polak JF, for the DCCT/EDIC Research Group, Backlund JC, Cleary PA, et al. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes. 2011;60(2):607–613.
   PubMed Web of Science ®Google Scholar
• Orchard TJ, Nathan DM, Zinman B, et al. Association between seven years of intensive treatment of type 1 diabetes and long term mortality. JAMA. 2015;313(1):45–53.
   PubMed Web of Science ®Google Scholar
• Tenjin A, Nagai Y, Yuji S, et al. Short-term change of carotid intima-media thickness after treatment of hyperglycemia in patients with diabetes: a cross-sectional study. BMC Res Notes. 2016;9(1):281.
   PubMedGoogle Scholar
• Shah AS, Dabelea D, Fino NF, et al. Predictors of increased carotid intima-media thickness in youth with type 1 diabetes: The SEARCH CVD Study. Dia Care. 2016;39(3):418–425.
   PubMed Web of Science ®Google Scholar
• Distiller LA, Joffe BI, Melville V, et al. Carotid artery intima-media complex thickening in patients with relatively long-surviving type 1 diabetes mellitus. J Diabetes Complications. 2006;20(5):280–284.
   PubMed Web of Science ®Google Scholar
• Cesana F, Giannattasio C, Nava S, et al. Impact of blood glucose variability on carotid artery intima media thickness and distensibility in type 1 diabetes mellitus. Blood Press. 2013;22(6):355–361.
   PubMed Web of Science ®Google Scholar
• Gül K, Üstün I, Aydin Y, et al. Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus. Anadolu Kardiyol Derg. 2010;10(1):52–58.
   PubMedGoogle Scholar
• Głowińska-Olszewska B, Urban M, Urban B, et al. The association of early atherosclerosis and retinopathy in adolescents with type 1 diabetes: preliminary report. Acta Diabetol. 2007;44(3):131–137.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim JH, Kang MJ, et al. Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care. 2011;34(10):2180–2185.
   PubMed Web of Science ®Google Scholar
• Atabek ME, Akyürek N, Eklioglu BS, et al. Impaired systolic blood dipping and nocturnal hypertension: an independent predictor of carotid intima-media thickness in type 1 diabetic patients. J Diabetes Complications. 2014;28(1):51–55.
   PubMed Web of Science ®Google Scholar
• Kozera GM, Wolnik B, Kunicka KB, et al. Cerebrovascular reactivity, intima-media thickness, and nephropathy presence in patients with type 1 diabetes. Diabetes Care. 2009;32(5):878–882.
   PubMed Web of Science ®Google Scholar
• Araszkiewicz A, Naskret D, Zozulinska-Ziolkiewicz D, et al. Skinautofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study. Microvasc Res. 2015;98:62–67.
   PubMed Web of Science ®Google Scholar
• Basu A, Jenkins AJ, Stoner JA, et al. Plasma homocysteine and carotid intima-media thickness in type 1 diabetes: A Prospective Study. Atherosclerosis. 2014;236(1):188–195.
   PubMed Web of Science ®Google Scholar
• Lilje C, Cardinale JP, Cronan J, et al. Femoral and aortic intima-media thickness but not carotid or brachial intima-media thickness are abnormal in children with type 1 diabetes. Cardiology. 2015;131(Suppl 02):179–179.
   Google Scholar
• Araszkiewicz A, Zozulinska-Ziolkiewicz D, Pilacinski S, et al. Baseline diabetic knowledge after 5-day teaching program is an independent predictor of subclinical macroangiopathy in patients with type 1 diabetes (Poznan Prospective Study). Adv Med Sci. 2014;59(2):240–244.
   PubMed Web of Science ®Google Scholar
• Raggi P, Shaw LJ, Berman DS, et al. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43(9):1663–1669.
   PubMed Web of Science ®Google Scholar
• Elkeles RS, for the PREDICT Study Group, Godsland IF, Feher MD, et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J. 2008;29(18):2244–2251.
   PubMed Web of Science ®Google Scholar
• Hoff JA, Quinn L, Sevrukov A, et al. The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am CollCardiol. 2003;41(6):1008–1012.
   Web of Science ®Google Scholar
• Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care. 2001;24(2):335–338.
   PubMed Web of Science ®Google Scholar
• Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am CollCardiol. 1990;15(4):827–832.
   Web of Science ®Google Scholar
• Djaberi R, Schuijf JD, de Koning EJ, et al. Usefulness of carotid intima-media thickness in patients with diabetes mellitus as a predictor of coronary artery disease. Am J Cardiol. 2009;104(8):1041–1046.
   PubMed Web of Science ®Google Scholar
• Snell-Bergeon JK, Hokanson JE, Jensen L, et al. Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care. 2003;26(10):2923–2928.
   PubMed Web of Science ®Google Scholar
• Cleary PA, DCCT/EDIC Research Group, Orchard TJ, Genuth S, et al. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 2006;55(12):3556–3565.
   PubMed Web of Science ®Google Scholar
• Snell-Bergeon JK, Roman R, Rodbard D, et al. Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study. Diabet Med. 2010;27(12):1436–1442.
   PubMed Web of Science ®Google Scholar
• Madrigal JM, Monson RS, Hatipoglu B, et al. Coronary artery calcium may stabilize following islet cell transplantation in patients with type 1 diabetes. Clin Transplant. 2017;31(10):e13059.
   Web of Science ®Google Scholar
• Olson JC, Edmundowicz D, Becker DJ, et al. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes. 2000;49(9):1571–1578.
   PubMed Web of Science ®Google Scholar
• Rodrigues TC, Veyna AM, Haarhues MD, et al. Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study. DiabetesTechnolTher. 2011;13(10):991–996.
   Google Scholar
• Maahs DM, Jalal D, Chonchol M, et al. Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study. Dia Care. 2013;36(9):2607–2614.
   PubMed Web of Science ®Google Scholar
• Maahs DM, Snell-Bergeon JK, Kinney G, et al. ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification. J. Diabetes Complicat. 2007;21(5):273–279.
   PubMed Web of Science ®Google Scholar
• de Boer IH, Gao X, Cleary PA, et al. Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes: the DCCT/EDIC study. CJASN. 2016;11(11):1969–1977.
   PubMed Web of Science ®Google Scholar
• Rodrigues TC, Ehrlich J, Hunter CM, et al. Reduced heart rate variability predicts progression of coronary artery calcification in adults with type 1 diabetes and controls without diabetes. Diabetes Technol. Ther. 2010;12(12):963–969.
   PubMed Web of Science ®Google Scholar
• Mogensen UM, Jensen T, Køber L, et al. Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes. 2012;61(7):1822–1830.
   PubMed Web of Science ®Google Scholar
• Burge MR, Eaton RP, Schade DS. The role of a coronary artery calcium scan in type 1 diabetes. Diabetes Technol. Ther. 2016;18(9):594–603.
   PubMed Web of Science ®Google Scholar
• Sehestedt T, Jeppesen J, Hansen TW, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31(7):883–891.
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121(4):505–511.
   PubMed Web of Science ®Google Scholar
• Prince CT, Secrest AM, Mackey RH, et al. Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes. Diabetes Care. 2010;33(3):652–657.
   PubMed Web of Science ®Google Scholar
• Prince CT, Secrest AM, Mackey RH, et al. Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes. Atherosclerosis. 2010;213(2):469–474.
   PubMed Web of Science ®Google Scholar
• Jensen-Urstad K, Reichard P, Jensen-Urstad M. Decreased heart rate variability in patients with type 1 diabetes mellitus is related to arterial wall stiffness. J. Intern. Med. 1999;245(1):57–61.
   PubMed Web of Science ®Google Scholar
• Lacy PS, O’Brien DG, Stanley AG, et al. Increased pulse wave velocity is not associated with elevated augmentation index in patients with diabetes. J Hypertens. 2004;22(10):1937–1944.
   PubMed Web of Science ®Google Scholar
• Shah AS, Wadwa RP, Dabelea D, et al. Arterial stiffness in adolescents and young adults with and without type 1 diabetes: the SEARCH CVD study. Pediatr Diabetes. 2015;16(5):367–374.
   PubMed Web of Science ®Google Scholar
• Theilade S, Lajer M, Persson F, et al. Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care. 2013;36(3):715–721.
   PubMed Web of Science ®Google Scholar
• Dabelea D, Talton JW, D'Agostino R, Jr, et al. Cardiovascular risk factors are associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013;36(12):3938–3943.
   PubMed Web of Science ®Google Scholar
• Shah AS, Black RS, Wadwa RP, et al. Insulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. J Diabetes Complications. 2015;29(4):512–516.
   PubMed Web of Science ®Google Scholar
• Jaiswal M, Urbina EM, Wadwa RP, et al. Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013;36(8):2351–2358.
   PubMed Web of Science ®Google Scholar
• Szczyrba S, Kozera GM, Neubauer-Geryk J, et al. Diabetic symmetric polyneuropathy is associated with increased aortal stiffening but not cerebral angiopathy in type 1 diabetes. J Diabetes Complications. 2015;29(1):73–76.
   PubMed Web of Science ®Google Scholar
• Araszkiewicz A, Rogowicz-Frontczak A, Zozulińska-Ziółkiewicz D, et al. Presence of retinopathy in type 1 diabetic patients is associated with subclinical macroangiopathy. Scand. J. Clin. Lab. Invest. 2011;71(7):563–568.
   PubMed Web of Science ®Google Scholar
• Roos CJ, Djaberi R, Schuijf JD, et al. Relationship between vascular stiffness and stress myocardial perfusion imaging in asymptomatic patients with diabetes. Eur J Nucl Med Mol Imaging. 2011;38(11):2050–2057.
   PubMed Web of Science ®Google Scholar
• Bjornstad P, Maahs DM, Duca LM, et al. Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the Coronary Artery Calcification in Type 1 Diabetes Study. J. Diabetes Complicat. 2016;30(4):586–590.
   PubMed Web of Science ®Google Scholar
• Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944–948.
   PubMed Web of Science ®Google Scholar
• Loh K, Deng H, Fukushima A, et al. Reactive oxygen species enhance insulin sensitivity. Cell Metab. 2009;10(4):260–272.
   PubMed Web of Science ®Google Scholar
• Jaffa MA, DCCT/EDIC Research Group, Luttrell D, Schmaier AH, et al. Plasma prekallikrein is associated with carotid intima-media thickness in type 1 diabetes. Diabetes. 2016;65(2):498–502.
   PubMed Web of Science ®Google Scholar
• Lp-PLA2 Studies Collaboration. Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. 2010;375(9725):1536–1544.
   PubMed Web of Science ®Google Scholar
• Reddy KJ, Singh M, Bangit JR, et al. The role of lipoprotein-associated phospholipase A2 on cardiovascular disease risk assessment and plaque rupture: a clinical review. J ClinLipidol. 2009;3(2):85–93.
   PubMed Web of Science ®Google Scholar
• Jarvie JL, Wang H, Kinney GL, et al. Lipoprotein-associated phospholipase A2 distribution among lipoproteins differs in type 1 diabetes. J ClinLipidol. 2016;10(3):577–586.
   PubMed Web of Science ®Google Scholar
• Basu A, Jenkins AJ, Zhang Y, et al. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes. Atherosclerosis. 2016;244:93–100.
   PubMed Web of Science ®Google Scholar
• Keenan HA, Costacou T, Sun JK, et al. Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care. 2007;30(8):1995–1997.
   PubMed Web of Science ®Google Scholar
• Adamsson Eryd S, Svensson A-M, Franzén S, et al. Risk of future microvascular and macrovascular disease in people with type 1 diabetes of very long duration: a national study with 10-year follow-up. Diabet Med. 2017;34(3):411–418.
   PubMed Web of Science ®Google Scholar
• Liu SL, Gurfinkel R, Spaic T, et al. The LONGevity & Type 1 Diabetes Macrovascular Epidemiology (LONGTIME) Study: carotid intima media thickness, LV strain and endothelial dysfunction in type 1 diabetes of 50 years duration. Canadian Journal of Diabetes. 2016;40(5):S8.
   Google Scholar
• Bain SC, Gill GV, Dyer PH, et al. Characteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet. Med. 2003;20(10):808–811.
   PubMed Web of Science ®Google Scholar
• Riddle MC, Bakris G, Blonde L, et al. American Diabetes Association Standards of Medical Care in Diabetes – 2018. Diabetes Care. 2018;41(Suppl. 1):86–104.
   Google Scholar
• Cosentino F, ESC Scientific Document Group, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. 2020;41(2):255–323., Grant PJ, Aboyans V,.
   PubMed Web of Science ®Google Scholar
• de Ferranti SD, de Boer IH, Fonseca V, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014;130(13):1110–1130.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27(6):314–340.
   PubMed Web of Science ®Google Scholar
• Catapano AL, Graham I, De Backer G, ESC Scientific Document Group, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37(39):2999–3058.
   PubMed Web of Science ®Google Scholar
• Djaberi R, Schuijf JD, Boersma E, et al. Differences in atherosclerotic plaque burden and morphology between type 1 and 2 diabetes as assessed by multislice computed tomography. Diabetes Care. 2009;32(8):1507–1512.
   PubMed Web of Science ®Google Scholar
• Budoff M, Backlund JC, Bluemke DA, et al. The association of coronary artery calcification with subsequent incidence of cardiovascular disease in type 1 diabetes: the DCCT/EDIC trials. JACC Cardiovasc Imaging. 2019 ;12(7):1341–1349.
   PubMed Web of Science ®Google Scholar
• Keshawarz A, Pyle L, Alman A, et al. Type 1 diabetes accelerates progression of coronary artery calcium over the menopausal transition: the CACTI study. Dia Care. 2019;42(12):2315–2321. Dec
   PubMed Web of Science ®Google Scholar
• Alharby H, Abdelati T, Rizk M, et al. Association of lipid peroxidation and interleukin-6 with carotid atherosclerosis in type 2 diabetes. Cardiovasc Endocrinol Metab. 2019;8(3):73–76.
   PubMed Web of Science ®Google Scholar
• Sousa GR, Pober D, Galderisi A, et al. Glycemic control, cardiac autoimmunity, and long-term risk of cardiovascular disease in type 1 diabetes mellitus. Circulation. 2019;139(6):730–743.
   PubMed Web of Science ®Google Scholar
• Jenkins A, Januszewski A, O'Neal D. The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it. Cardiovasc Endocrinol Metab. 2019;8(1):14–27.
   PubMed Web of Science ®Google Scholar